Drugs / Decubal
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06427889 Comparator | Sep 2024 → Nov 2025 overdue | diabetes mellitus | Malmö University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Decubal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06427889 ↗ |
| Known as | Decuballipid cream | “the opposite foot will be treated with the comparator cream (Decubal®lipid cream), twice a day.” NCT06427889 ↗ |
| Route | Topical | “Topical on feet twice a day” NCT06427889 ↗ |